Blog
RSS FeedPosted by Michael Wonder on 01 Feb 2024
Biden-Harris Administration to make first offer for drug price negotiation program, launches new resource hub to help people access lower cost drugs
1 February 2024 - Department of Human and Health Services also releases new research showing that the United States pays ...
Posted by Michael Wonder on 29 Jan 2024
At 40, Medicare’s a marvel but it’s time for a health check
30 January 2024 - Big birthdays are a moment for reflection. And at 40, many of us need a check-up to ...
Posted by Michael Wonder on 29 Jan 2024
Will Medicare push drug prices down in 2024?
29 January 2024 - Medicare participants will get insight this year into how much the prices of certain drugs will ...
Posted by Michael Wonder on 29 Jan 2024
Commemorating 40 years of Medicare
29 January 2024 - The Australian Government is releasing a special edition Medicare card in 2024 to commemorate the 40th anniversary ...
Posted by Michael Wonder on 19 Jan 2024
Medicare patients on pricey drugs are saving big this year
15 January 2024 - For the first time, Part D plan patients will hit a ceiling on how much they pay ...
Posted by Michael Wonder on 16 Dec 2023
Has the Centers for Medicare Medicaid Services implicitly adopted a value framework for Medicare drug price negotiations?
15 December 2023 - The US Inflation Reduction Act of 2022 created several major policy changes to the pricing of prescription ...
Posted by Michael Wonder on 14 Dec 2023
CMS releases revised guidance for Medicare prescription drug inflation rebate program
14 December 2023 - Under President Biden’s lower cost prescription drug law, drug companies will pay rebates to Medicare for ...
Posted by Michael Wonder on 06 Dec 2023
Reimbursement to pharmacies for generic drugs by Medicare Part D sponsors
5 December 2023 - Pharmacy benefit managers (PBMs) manage prescription drug benefits on behalf of health insurers; PBMs negotiate reimbursements for ...
Posted by Michael Wonder on 27 Nov 2023
Cost of exempting sole orphan drugs from Medicare negotiation
27 November 2023 - This cross-sectional study identified 25 “sole orphan” drugs qualifying for exemption from Medicare price negotiation. ...
Posted by Michael Wonder on 20 Nov 2023
Janssen submits supplemental biologics license application to US FDA seeking approval of Rybrevant (amivantamab-vmjw) plus chemotherapy for the treatment of patients with EGFR mutated non-small-cell lung cancer who progressed on or after osimertinib
20 November 2023 - This submission is supported by data from the Phase 3 MARIPOSA-2 Study featured in a Late-Breaking Presidential ...
Posted by Michael Wonder on 04 Nov 2023
Medicare is urged to consider Amgen patent manoeuvres when negotiating the price for a drug
31 October 2023 - As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group argues ...
Posted by Michael Wonder on 01 Nov 2023
Medicare bulk billing strengthened as largest investment in 40 years takes effect
1 November 2023 - The Australian Government is making it easier to see a bulk billing doctor for more than 11 ...
Posted by Michael Wonder on 13 Oct 2023
Outcomes of the September 2023 PBAC intracycle meeting
13 October 2023 - The outcomes from the September 2023 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 11 Oct 2023
Will Medicare price negotiation delay cancer drug launches?
11 October 2023 - On 29 August 2023, the Biden administration announced the first 10 drugs selected for Medicare price ...
Posted by Michael Wonder on 05 Oct 2023
Building a stronger Medicare with MyMedicare now open to patients
5 October 2023 - The Australian Government is laying the foundations for a stronger Medicare, with the new MyMedicare program open ...